drugset / Trial / NCT03705949

Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery

NCT03705949

RandomizedParallel-groupSingle-blindPrevention

Summary

Primary objective of the study is the assessment of the patients' discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

Timeline

Start
2017-09-15
Primary completion
2018-09-15
Completion
2018-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Hyaluronate Other / unclassified 0.1 % Topical
Comparator Sodium Hyaluronate Other / unclassified 0.2 % Topical

Indications